BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21636274)

  • 1. Syntheses of 2-NBDG analogues for monitoring stereoselective uptake of D-glucose.
    Yamamoto T; Tanaka S; Suga S; Watanabe S; Nagatomo K; Sasaki A; Nishiuchi Y; Teshima T; Yamada K
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4088-96. PubMed ID: 21636274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A real-time method of imaging glucose uptake in single, living mammalian cells.
    Yamada K; Saito M; Matsuoka H; Inagaki N
    Nat Protoc; 2007; 2(3):753-62. PubMed ID: 17406637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant Uptake of a Fluorescent L-Glucose Analogue (fLG) into Tumor Cells Expressing Malignant Phenotypes.
    Yamada K
    Biol Pharm Bull; 2018; 41(10):1508-1516. PubMed ID: 30270319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-NBDG as a fluorescent indicator for direct glucose uptake measurement.
    Zou C; Wang Y; Shen Z
    J Biochem Biophys Methods; 2005 Sep; 64(3):207-15. PubMed ID: 16182371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel use of fluorescent glucose analogues to identify a new class of triazine-based insulin mimetics possessing useful secondary effects.
    Jung DW; Ha HH; Zheng X; Chang YT; Williams DR
    Mol Biosyst; 2011 Feb; 7(2):346-58. PubMed ID: 20927436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Existence of two parallel mechanisms for glucose uptake in heterotrophic plant cells.
    Etxeberria E; González P; Tomlinson P; Pozueta-Romero J
    J Exp Bot; 2005 Jul; 56(417):1905-12. PubMed ID: 15911561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of fluorescent glucose bioprobes and their application on real-time and quantitative monitoring of glucose uptake in living cells.
    Lee HY; Lee JJ; Park J; Park SB
    Chemistry; 2011 Jan; 17(1):143-50. PubMed ID: 21207611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular fate of 2-NBDG, a fluorescent probe for glucose uptake activity, in Escherichia coli cells.
    Yoshioka K; Saito M; Oh KB; Nemoto Y; Matsuoka H; Natsume M; Abe H
    Biosci Biotechnol Biochem; 1996 Nov; 60(11):1899-901. PubMed ID: 8987871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syntheses of D-Glucose Derivatives Emitting Blue Fluorescence through Pd-Catalyzed C-N Coupling.
    Otsuka Y; Sasaki A; Teshima T; Yamada K; Yamamoto T
    Org Lett; 2016 Mar; 18(6):1338-41. PubMed ID: 26987885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel fluorescent derivative of glucose applicable to the assessment of glucose uptake activity of Escherichia coli.
    Yoshioka K; Takahashi H; Homma T; Saito M; Oh KB; Nemoto Y; Matsuoka H
    Biochim Biophys Acta; 1996 Feb; 1289(1):5-9. PubMed ID: 8605231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of fluorescent D- and L-glucose analogues, 2-NBDG and 2-NBDLG, into human osteosarcoma U2OS cells in a phloretin-inhibitable manner.
    Ogawa T; Sasaki A; Ono K; Ohshika S; Ishibashi Y; Yamada K
    Hum Cell; 2021 Mar; 34(2):634-643. PubMed ID: 33454890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confocal microscopy study of the different patterns of 2-NBDG uptake in rabbit enterocytes in the apical and basal zone.
    Román Y; Alfonso A; Louzao MC; Vieytes MR; Botana LM
    Pflugers Arch; 2001 Nov; 443(2):234-9. PubMed ID: 11713649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining glucose transport in single vascular smooth muscle cells with a fluorescent glucose analog.
    Lloyd PG; Hardin CD; Sturek M
    Physiol Res; 1999; 48(6):401-10. PubMed ID: 10783904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid viability assessment of yeast cells using vital staining with 2-NBDG, a fluorescent derivative of glucose.
    Oh KB; Matsuoka H
    Int J Food Microbiol; 2002 Jun; 76(1-2):47-53. PubMed ID: 12038577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of 2-NBDG as a method to monitor therapy response in breast cancer cell lines.
    Millon SR; Ostrander JH; Brown JQ; Raheja A; Seewaldt VL; Ramanujam N
    Breast Cancer Res Treat; 2011 Feb; 126(1):55-62. PubMed ID: 20390344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells.
    O'Neil RG; Wu L; Mullani N
    Mol Imaging Biol; 2005; 7(6):388-92. PubMed ID: 16284704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorometric determination of glucose utilization in neurons in vitro and in vivo.
    Itoh Y; Abe T; Takaoka R; Tanahashi N
    J Cereb Blood Flow Metab; 2004 Sep; 24(9):993-1003. PubMed ID: 15356420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of drug-induced cytotoxicity on glucose uptake in Hodgkin's lymphoma cells.
    Banning U; Barthel H; Mauz-Körholz C; Kluge R; Körholz D; Sabri O
    Eur J Haematol; 2006 Aug; 77(2):102-8. PubMed ID: 16800842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-NBDG fluorescence imaging of hypermetabolic circulating tumor cells in mouse xenograft model of breast cancer.
    Cai H; Peng F
    J Fluoresc; 2013 Jan; 23(1):213-20. PubMed ID: 23054302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Imaging of Glucose Metabolism for Intraoperative Fluorescence Guidance During Glioma Surgery.
    Belykh E; Jubran JH; George LL; Bardonova L; Healey DR; Georges JF; Quarles CC; Eschbacher JM; Mehta S; Scheck AC; Nakaji P; Preul MC
    Mol Imaging Biol; 2021 Aug; 23(4):586-596. PubMed ID: 33544308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.